[go: up one dir, main page]

EE03510B1 - Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine - Google Patents

Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine

Info

Publication number
EE03510B1
EE03510B1 EE9700105A EE9700105A EE03510B1 EE 03510 B1 EE03510 B1 EE 03510B1 EE 9700105 A EE9700105 A EE 9700105A EE 9700105 A EE9700105 A EE 9700105A EE 03510 B1 EE03510 B1 EE 03510B1
Authority
EE
Estonia
Prior art keywords
cisapride
preparation
dosage form
oral administration
sustained release
Prior art date
Application number
EE9700105A
Other languages
English (en)
Other versions
EE9700105A (et
Inventor
Marie Victor Gilis Paul
Marie Jozef Jans Eugene
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE9700105A publication Critical patent/EE9700105A/et
Publication of EE03510B1 publication Critical patent/EE03510B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
EE9700105A 1994-11-02 1995-10-25 Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine EE03510B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02
PCT/EP1995/004198 WO1996014070A1 (en) 1994-11-02 1995-10-25 Cisapride extended release oral compositions

Publications (2)

Publication Number Publication Date
EE9700105A EE9700105A (et) 1997-12-15
EE03510B1 true EE03510B1 (et) 2001-10-15

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700105A EE03510B1 (et) 1994-11-02 1995-10-25 Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine

Country Status (29)

Country Link
US (2) US6153623A (et)
EP (1) EP0789572A1 (et)
JP (1) JP3182423B2 (et)
KR (1) KR100255521B1 (et)
AP (1) AP658A (et)
AR (1) AR001765A1 (et)
AU (1) AU704284B2 (et)
BG (1) BG63244B1 (et)
BR (1) BR9509565A (et)
CA (1) CA2203663C (et)
CZ (1) CZ287844B6 (et)
EE (1) EE03510B1 (et)
FI (1) FI971856L (et)
HR (1) HRP950539A2 (et)
HU (1) HUT77887A (et)
IL (1) IL115843A0 (et)
MY (1) MY113092A (et)
NO (1) NO312538B1 (et)
NZ (1) NZ295166A (et)
OA (1) OA10419A (et)
PL (1) PL181470B1 (et)
RO (1) RO116042B1 (et)
RU (1) RU2143890C1 (et)
SK (1) SK54297A3 (et)
TR (1) TR199501351A2 (et)
TW (1) TW466114B (et)
UA (1) UA50721C2 (et)
WO (1) WO1996014070A1 (et)
ZA (1) ZA959221B (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
WO1997020562A1 (en) * 1995-12-01 1997-06-12 Janssen Pharmaceutica N.V. Cisapride sustained release
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
CA2275604A1 (en) * 1997-01-03 1998-07-09 Kenneth Iain Cumming Sustained release cisapride mini-tablet formulation
KR20010012104A (ko) * 1997-06-11 2001-02-15 디르크 반테 (+)- 또는 (-)-시사프라이드의 즉시 방출 ｐＨ-비의존적 고체 제형
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
CO5140079A1 (es) * 1998-10-14 2002-03-22 Novartis Ag Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
ES2255490T3 (es) 1999-03-31 2006-07-01 Janssen Pharmaceutica N.V. Almidon pregelatinizado en una formulacion de liberacion controlada.
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
AU774099B2 (en) * 1999-09-28 2004-06-17 Panacea Biotec Limited Controlled release compositions comprising nimesulide
SI1345595T1 (sl) * 2000-09-29 2007-08-31 Solvay Pharm Bv Farmacevtska oblika s podaljĺ anim sproĺ äśanjem, ki je neodvisna od ionske jakosti
ES2312525T3 (es) * 2002-05-21 2009-03-01 Watson Laboratories, Inc. Formulacion farmaceutica con liberacion prolongada.
CN101420937B (zh) 2006-04-12 2011-06-22 日本曹达株式会社 缓释性片剂的制造方法
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
DE69322077T2 (de) * 1992-03-25 1999-04-08 Depomed, Inc., Foster City, Calif. Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
CA2139638A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
CZ287844B6 (en) 2001-02-14
CZ124497A3 (en) 1997-08-13
CA2203663C (en) 2002-04-30
US6153623A (en) 2000-11-28
FI971856A7 (fi) 1997-04-30
IL115843A0 (en) 1996-01-31
KR100255521B1 (ko) 2000-05-01
AU3844795A (en) 1996-05-31
BG101401A (bg) 1997-12-30
FI971856A0 (fi) 1997-04-30
TR199501351A2 (tr) 1996-06-21
UA50721C2 (uk) 2002-11-15
ZA959221B (en) 1997-04-30
JPH09511760A (ja) 1997-11-25
US6274599B1 (en) 2001-08-14
CA2203663A1 (en) 1996-05-17
NO971832L (no) 1997-04-21
AU704284B2 (en) 1999-04-15
NZ295166A (en) 1999-03-29
EP0789572A1 (en) 1997-08-20
HUT77887A (hu) 1998-09-28
RU2143890C1 (ru) 2000-01-10
OA10419A (en) 2001-12-06
FI971856L (fi) 1997-04-30
EE9700105A (et) 1997-12-15
AR001765A1 (es) 1997-12-10
AP658A (en) 1998-08-17
NO312538B1 (no) 2002-05-27
JP3182423B2 (ja) 2001-07-03
TW466114B (en) 2001-12-01
NO971832D0 (no) 1997-04-21
MX9703249A (es) 1997-07-31
SK54297A3 (en) 1997-10-08
HRP950539A2 (en) 1997-08-31
PL319948A1 (en) 1997-09-01
RO116042B1 (ro) 2000-10-30
MY113092A (en) 2001-11-30
BR9509565A (pt) 1997-09-16
WO1996014070A1 (en) 1996-05-17
BG63244B1 (bg) 2001-07-31
PL181470B1 (pl) 2001-07-31
AP9700969A0 (en) 1997-04-30

Similar Documents

Publication Publication Date Title
EE04417B1 (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm, selle valmistamise meetod ja kasutamine
DK1043976T3 (da) Oral farmaceutisk doseringsform med langvarig frigivelse
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
EE03594B1 (et) Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
NO975831L (no) Nytt farmasöytisk preparat med anestetisk virkning
FI955248A7 (fi) 1-Bifenyylimetyyli-imitdatsolin johdannaiset, niiden valmistus ja terapeuttinen käyttö
EE200000723A (et) Asendatud indolinoonid, nende valmistamine ja nende kasutamine ravimitena
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
EE200100009A (et) Bensimidasoolid, nende valmistamine ja kasutamineravimitena
EE03510B1 (et) Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
EE200200160A (et) 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid
FI971188L (fi) Terapeuttinen vitamiini-kalsium yhdistelmä yksikköannoksena galeenisen tabletin muodossa, menetelmä sen valmistamiseksi ja sen käyttö
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
EE04954B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
FI922982A7 (fi) 2-aminopyrimidiini-4-karboksamidijohdannaisia, niiden valmistus ja niiden terapeuttinen käyttö
NO20002526L (no) Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav
EE03387B1 (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
EE9800451A (et) Uued imidasotriasolopürimidiinid, nende valmistamismeetod ja kasutamine ravimainetena
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine
EE200200551A (et) Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine
FI970750L (fi) Indoli-2,3-dioni-3-oksimijohdannaisia, niiden valmistus ja käyttö

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20041025